NPPA issued a notification regarding the fixation of the retail price of Atorvastatin Calcium IP eq. to Atorvastatin 20 mg + Ezetimibe IP 10 mg for M/s Pure & Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Mankind Pharma Ltd. (Marketer)

Jan 13, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on January 12, 2026, issued a notification regarding the fixation of the retail price of Atorvastatin Calcium IP eq. to Atorvastatin 20 mg + Ezetimibe IP 10 mg for M/s Pure & Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Mankind Pharma Ltd. (Marketer).

The following has been stated: -

•Each Film Coated Tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 20 mg + Ezetimibe IP 10 mg for M/s Pure & Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Mankind Pharma Ltd. (Marketer), and the retail price is 30.10 Rs.

[Notification No.:19(4981)/2025/DP/NPPA/Div.III/12894/2026]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT